5. Disclosures in accordance with art. 964b Swiss Code of Obligations

The following sections comprise the report on non-financial matters in accordance with art. 964b of the Swiss Code of Obligations (the “CO”), which includes an independent practitioner’s limited assurance report on selected non-financial information, including a selected set of performance indicators. The consultative vote on the report on non-financial matters for the financial year 2024 at the 2025 annual general meeting is limited to the content of these sections.

Art. 964b CO content requirement

Section

Reference

Article links

 

 

 

 

General information required to understand our business

Introduction

Page 18

https://report.polypeptide.com/ar/24/en/?p=2214

Sustainability approach

Page 19-20

https://report.polypeptide.com/ar/24/en/?p=2169

Overview–Strategy

Page 10-13

https://report.polypeptide.com/ar/24/en/?p=2344

 

Reporting on the material ESG topics

Page 26-39

https://report.polypeptide.com/ar/24/en/?p=2297

Description of the business model

Introduction

Page 18

https://report.polypeptide.com/ar/24/en/?p=2214

 

Overview–Strategy–Business model

Page 10-13

https://report.polypeptide.com/ar/24/en/?p=2344

Description of materiality assessment

Materiality and contribution to the SDGs–Identification of material topics

Page 23

https://report.polypeptide.com/ar/24/en/?p=2174

 

Materiality and contribution to the SDGs–Materiality matrix

Page 24

https://report.polypeptide.com/ar/24/en/?p=2174/#materialitymatrix

 

Reporting on the material ESG topics

Page 26-39

https://report.polypeptide.com/ar/24/en/?p=2297

Description of governance

Sustainability approach–Responsibilities and organization

Page 19-20

https://report.polypeptide.com/ar/24/en/?p=2169/#responsibilitiesandorganization

Environmental matters (in particular CO2 goals)

Green chemistry

Page 29

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistry

 

Climate change mitigation - see Climate Report

Page 40-65

https://report.polypeptide.com/ar/24/en/?p=2519

Main impacts, risks and opportunities

Green chemistry–Impact

Page 29-32

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistry

 

Climate change mitigation–Impact

Page 44-45

https://report.polypeptide.com/ar/24/en/?p=2522/#Impact

 

Green chemistry–Risks and opportunities

Page 29

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistry

 

Climate change mitigation–Risks and opportunities

Page 50

https://report.polypeptide.com/ar/24/en/?p=2523

Policies adopted, including the due diligence applied

Green chemistry–Approach–Policies and commitments

Page 30

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistrypolociesandcommitments

Climate change mitigation–Approach–Policies and commitments

Page 52

https://report.polypeptide.com/ar/24/en/?p=2524

Measures taken to implement policies and assessment of effectiveness

Green chemistry–Approach–Management of impacts, risks and opportunities

Page 29-31

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistryrisksandopportunities

 

Green chemistry–Approach–Achievements and challenges in 2024

Page 31

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistryachievements2024

 

Climate change mitigation–Approach–Management of impacts, risks and opportunities

Page 50

https://report.polypeptide.com/ar/24/en/?p=2523

 

Climate change mitigation–Approach–Achievements and challenges in 2024

Page 59

https://report.polypeptide.com/ar/24/en/?p=2524/#Transitionplan

Performance indicators

Green chemistry–Approach–Achievements and challenges in 2024

Page 31

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistryachievements2024

 

Climate change mitigation–Approach–Achievements and challenges in 2024

Page 59

https://report.polypeptide.com/ar/24/en/?p=2524/#Transitionplan

Social issues

Product responsibility

Page 27-29

https://report.polypeptide.com/ar/24/en/?p=2297/#productresponsibility

 

People

Page 34-37

https://report.polypeptide.com/ar/24/en/?p=2297/#people

Main impacts, risks and opportunities

Product responsibility–Impact

Page 27

https://report.polypeptide.com/ar/24/en/?p=2297/#productresponsibilityimpact

 

People–Impact

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleimpact

 

Product responsibility–Risks and opportunities

Page 27

https://report.polypeptide.com/ar/24/en/?p=2297/#productresponsibilityrisksandopportunities

 

People–Risks and opportunities

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplerisksandopportunities

Policies adopted, including the due diligence applied

Product responsibility–Approach–Policies and commitments

Page 27

https://report.polypeptide.com/ar/24/en/?p=2297/#productresponsibilitypoliciesandcommitments

People–Approach–Policies and commitments

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplepoliciesandcommitments

Measures taken to implement policies and assessment of effectiveness

Product responsibility–Approach–Management of impacts, risks and opportunities

Page 28

https://report.polypeptide.com/ar/24/en/?p=2297/#productresponsibilitymanagement

Product responsibility–Approach–Achievements and challenges in 2024

Page 28-29

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleresponsibilityachievements2024

People–Approach–Management of impacts, risks and opportunities

Page 35

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplemanagement

 

People–Approach–Achievements and challenges in 2024

Page 35-37

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

Performance indicators

Product responsibility–Approach–Achievements and challenges in 2024

Page 28-29

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleresponsibilityachievements2024

 

People–Approach–Achievements and challenges in 2024

Page 35-37

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

Employee-related issues

People

Page 34-37

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleimpact

Main impacts, risks and opportunities

People–Impact

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleimpact

 

People–Risks and opportunities

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplerisksandopportunities

Policies adopted, including the due diligence applied

People–Approach–Policies and commitments

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplepoliciesandcommitments

Measures taken to implement policies and assessment of effectiveness

People–Approach–Management of impacts, risks and opportunities

Page 35

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplemanagement

 

People–Approach–Achievements and challenges in 2024

Page 35-37

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

Performance indicators

People–Approach–Achievements and challenges in 2024

Page 35-37

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

Respect for human rights

Supply chain engagement

Page 32-33

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagement

 

People

Page 34-37

https://report.polypeptide.com/ar/24/en/?p=2297/#people

Main impacts, risks and opportunities

Supply chain engagement–Impact

Page 32

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementimpact

People–Impact

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleimpact

Supply chain engagement–Risks and opportunities

Page 32-33

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementrisksandopportunities

 

People–Risks and opportunities

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplerisksandopportunities

Policies adopted, including the due diligence applied

Supply chain engagement–Approach–Policies and commitments

Page 33

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementpoliciesandcommitments

People–Approach–Policies and commitments

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplepoliciesandcommitments

Measures taken to implement policies and assessment of effectiveness

Supply chain engagement–Approach–Management of impacts, risks and opportunities

Page 33

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementmanagement

Supply chain engagement–Approach–Achievements and challenges in 2024

Page 33

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementachievements2024

People–Approach–Management of impacts, risks and opportunities

Page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#peoplerisksandopportunities

 

People–Approach–Achievements and challenges in 2024

Page 35-37

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

Performance indicators

Supply chain engagement–Approach–Achievements and challenges in 2024

Page 33

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementachievements2024

 

People–Approach–Achievements and challenges in 2024

Page 35-37

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

Combating corruption

Business ethics and compliance

Page 37-39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliance

Main impacts, risks and opportunities

Business ethics and compliance–Impact

Page 37

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceimpact

 

Business ethics and compliance–Risks and opportunities

Page 37

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliancerisksandopportunities

Policies adopted, including the due diligence applied

Business ethics and compliance–Approach–Policies and commitments

Page 38

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliancepoliciesandcommitments

Measures taken to implement policies and assessment of effectiveness

Business ethics and compliance–Approach–Management of impacts, risks and opportunities

Page 38-39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliancepoliciesandcommitments

 

Business ethics and compliance–Approach–Achievements and challenges in 2024

Page 39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceachievements2024

Performance indicators

Business ethics and compliance–Approach–Achievements and challenges in 2024

Page 39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceachievements2024

References to national, European or international regulations

Introduction

Page 18

https://report.polypeptide.com/ar/24/en/?p=2214

GRI content index

Page 72

https://report.polypeptide.com/ar/24/en/?p=2189

Coverage of subsidiaries

Sustainability approach

Page 19-21

https://report.polypeptide.com/ar/24/en/?p=2169

Art. 964j-l CO requirements

Section

Reference

Article links

 

 

 

 

PolyPeptide’s due diligence in relation to minerals and metals from conflict-affected areas

Supply chain engagement–Approach

Page 32

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementapproach

PolyPeptide's voluntary report on child labor due diligence in its supply chain

Page 69-71

https://report.polypeptide.com/ar/24/en/?p=2223

PolyPeptide's due diligence in relation to child labor

Supply chain engagement–Approach

Page 32

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementapproach

 

PolyPeptide's voluntary report on child labor due diligence in its supply chain

Page 69-71

https://report.polypeptide.com/ar/24/en/?p=2223

The report on non-financial matters for the financial year 2024 was approved for publication by the Board of Directors on 10 March 2025, and will be presented to the General Meeting of shareholders for a consultative vote on 9 April 2025.

Peter Wilden, Chair
Patrick Aebischer, Vice-Chair and Lead Independent Director
Jane Salik, Member
Erik Schropp, Member
Beat In-Albon, Independent Member
Philippe Weber, Independent Member

Baar, 10 March 2025

On behalf of the entire Board of Directors and the Executive Committee,

Peter Wilden

Chair of the Board of Directors

Juan José González

CEO